ALZHEIMER'S CLINICAL TRIAL CONSORTIUM FOR DOWN SYNDROME (ACTC-DS) TRIAL-READY COHORT - DOWN SYNDROME (TRC-DS)

Primary Objective

TRC-DS is a community of clinical trial volunteers who could help find a cure for Alzheimer's disease for people with Down syndrome.

Is This Study For You?

Let's Get Started!

Description

TRC-DS is part of a larger movement working with people with Down syndrome to advance Alzheimer's disease therapies and potential cures for this population. The Alzheimer's Clinical Trials Consortium-Down Syndrome (ACTC-DS) is a large collaboration of researchers conducting clinical trials for Alzheimer's disease in people with Down syndrome. The University of Colorado has partnered with the ACTC-DS to participate on the Anschutz Medical Campus. TRC-DS is the first of these studies and has the goal of creating a group of eligible volunteers with Down syndrome who are interested in participating in future clinical trials.

Details
Age
Adult
Eligibility
Are healthy adults, between ages 35-55, with Down syndrome; Have an interest in participating in clinical research; Will visit the University of Colorado Linda Crnic Institute once every 16 months for routine exams and brain scans.
Locations

Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Joaquin Espinosa

Joaquin Espinosa

Study ID

Protocol Number: 20-2692

More information available at ClinicalTrials.gov: NCT04165109

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers